Cargando…

Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial

PURPOSE: To determine the feasibility of implementing a yoga intervention for cancer survivors with chronic CIPN pain, as well as the impact of the intervention on patient-reported outcomes. METHODS: Cancer survivors with chronic CIPN pain were recruited from the breast, gastrointestinal, and gyneco...

Descripción completa

Detalles Bibliográficos
Autores principales: Knoerl, Robert, Giobbie-Hurder, Anita, Berfield, Juliana, Berry, Donna, Meyerhardt, Jeffrey A., Wright, Alexi A., Ligibel, Jennifer A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442518/
https://www.ncbi.nlm.nih.gov/pubmed/34524631
http://dx.doi.org/10.1007/s11764-021-01081-z
_version_ 1783753023722356736
author Knoerl, Robert
Giobbie-Hurder, Anita
Berfield, Juliana
Berry, Donna
Meyerhardt, Jeffrey A.
Wright, Alexi A.
Ligibel, Jennifer A.
author_facet Knoerl, Robert
Giobbie-Hurder, Anita
Berfield, Juliana
Berry, Donna
Meyerhardt, Jeffrey A.
Wright, Alexi A.
Ligibel, Jennifer A.
author_sort Knoerl, Robert
collection PubMed
description PURPOSE: To determine the feasibility of implementing a yoga intervention for cancer survivors with chronic CIPN pain, as well as the impact of the intervention on patient-reported outcomes. METHODS: Cancer survivors with chronic CIPN pain were recruited from the breast, gastrointestinal, and gynecological oncology centers at Dana-Farber Cancer Institute. Participants were randomized (2:1) to receive an 8-week yoga intervention or usual care. After 21/50 of participants were enrolled, the COVID-19 pandemic required the yoga intervention to be delivered virtually (i.e., Zoom). Pre- and post-intervention, participants self-reported CIPN and co-occurring symptom severity. Adherence to the intervention was defined as practicing ≥ 12 yoga sessions over the 8-week intervention period. Changes in patient-reported outcomes between groups were compared using Wilcoxon’s rank-sum tests. RESULTS: Participants (n = 28 yoga, n = 16 control) were mainly female (96%) and diagnosed with stage III/IV disease (66%). Overall, 19/28 (67.8%) of yoga group participants were adherent to the yoga protocol. Yoga group participants experienced significant within-group improvements in all patient-reported outcomes, including worst CIPN pain (median change =  − 1.7, p < 0.0001) and sensory CIPN (median change =  − 14.8, p < 0.0001), but only improvements in fatigue (p = 0.05) and depression (p = 0.04) were significant compared to the control. There were no differences (p > 0.05) in changes in patient-reported outcomes between in-person (n = 6) or virtual (n = 15) yoga group participants. CONCLUSIONS: Yoga is a feasible non-pharmacological modality for cancer survivors with CIPN, but more information is needed regarding its impact on CIPN and other symptoms. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03824860 IMPLICATIONS FOR CANCER SURVIVORS: Oncology clinicians may consider referring cancer survivors to yoga for chronic CIPN pain, but yoga cannot be currently recommended as an efficacious treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11764-021-01081-z.
format Online
Article
Text
id pubmed-8442518
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-84425182021-09-15 Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial Knoerl, Robert Giobbie-Hurder, Anita Berfield, Juliana Berry, Donna Meyerhardt, Jeffrey A. Wright, Alexi A. Ligibel, Jennifer A. J Cancer Surviv Article PURPOSE: To determine the feasibility of implementing a yoga intervention for cancer survivors with chronic CIPN pain, as well as the impact of the intervention on patient-reported outcomes. METHODS: Cancer survivors with chronic CIPN pain were recruited from the breast, gastrointestinal, and gynecological oncology centers at Dana-Farber Cancer Institute. Participants were randomized (2:1) to receive an 8-week yoga intervention or usual care. After 21/50 of participants were enrolled, the COVID-19 pandemic required the yoga intervention to be delivered virtually (i.e., Zoom). Pre- and post-intervention, participants self-reported CIPN and co-occurring symptom severity. Adherence to the intervention was defined as practicing ≥ 12 yoga sessions over the 8-week intervention period. Changes in patient-reported outcomes between groups were compared using Wilcoxon’s rank-sum tests. RESULTS: Participants (n = 28 yoga, n = 16 control) were mainly female (96%) and diagnosed with stage III/IV disease (66%). Overall, 19/28 (67.8%) of yoga group participants were adherent to the yoga protocol. Yoga group participants experienced significant within-group improvements in all patient-reported outcomes, including worst CIPN pain (median change =  − 1.7, p < 0.0001) and sensory CIPN (median change =  − 14.8, p < 0.0001), but only improvements in fatigue (p = 0.05) and depression (p = 0.04) were significant compared to the control. There were no differences (p > 0.05) in changes in patient-reported outcomes between in-person (n = 6) or virtual (n = 15) yoga group participants. CONCLUSIONS: Yoga is a feasible non-pharmacological modality for cancer survivors with CIPN, but more information is needed regarding its impact on CIPN and other symptoms. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03824860 IMPLICATIONS FOR CANCER SURVIVORS: Oncology clinicians may consider referring cancer survivors to yoga for chronic CIPN pain, but yoga cannot be currently recommended as an efficacious treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11764-021-01081-z. Springer US 2021-09-15 2022 /pmc/articles/PMC8442518/ /pubmed/34524631 http://dx.doi.org/10.1007/s11764-021-01081-z Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Knoerl, Robert
Giobbie-Hurder, Anita
Berfield, Juliana
Berry, Donna
Meyerhardt, Jeffrey A.
Wright, Alexi A.
Ligibel, Jennifer A.
Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial
title Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial
title_full Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial
title_fullStr Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial
title_full_unstemmed Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial
title_short Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial
title_sort yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442518/
https://www.ncbi.nlm.nih.gov/pubmed/34524631
http://dx.doi.org/10.1007/s11764-021-01081-z
work_keys_str_mv AT knoerlrobert yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial
AT giobbiehurderanita yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial
AT berfieldjuliana yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial
AT berrydonna yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial
AT meyerhardtjeffreya yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial
AT wrightalexia yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial
AT ligibeljennifera yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial